Ads
related to: revlimid- Treatment Option
Find Out More Info About Jaypirca.
Learn About a Treatment Option.
- Learn About Jaypirca
Find Out About Jaypirca.
Read More on the Official Site.
- Taking Jaypirca
Dosing Information.
Side Effects and Safety.
- Support and Resources
Find Out If You Qualify For
Financial Assistance.
- Treatment Option
Search results
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
Benzinga via Yahoo Finance· 2 years agoBristol Myers Squibb & Co (NYSE: BMY) said that its Q3 sales of $11.22 billion fell 3% Y/Y as...
Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming
Investor's Business Daily· 1 year agoBristol Myers Squibb's Revlimid took fewer than expected generic hits in the fourth quarter,...
Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales
Zacks via Yahoo Finance· 1 year agoBristol-Myers' (BMY) fourth-quarter 2022 earnings beat estimates, while sales declined year over...
Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered
Zacks via Yahoo Finance· 10 months agoBristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion...
Bristol Myers' profit beats on better-than-feared Revlimid sales
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts'...
Bristol Myers profit beats estimates on resilient Revlimid sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Bristol Myers Squibb Co on Wednesday reported bigger second-quarter profit than expected...
Bristol Myers sales fall, cuts 2023 forecast as drugs face competition
Reuters via Yahoo Finance· 10 months ago(Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni...
Benzinga via Yahoo Finance· 1 year agoView more earnings on BMYDon't miss real-time alerts on your stocks - join Benzinga Pro for free!...
Is Bristol Myers Squibb Stock a Buy Now?
Motley Fool via Yahoo Finance· 4 months agoIt's not exactly fun to be one of Bristol Myers Squibb's (NYSE: BMY) shareholders right now. The company's stock dropped by 31% in the past year, some of...
Ads
related to: revlimid